Comparison of the effects of ipratropium bromide and salbutamol on autonomic heart rate control

Europace

Volumn 6, Issue 6, 2004, Pages 602-607

  Kaya, Dayimi ^a   Barutcu, Irfan ^b,d   Esen, Ali Metin ^b   Onrat, Ersel ^c   Orman, Ayse ^c   Unlu, Mehmet ^c  

^a Ege Saglik Hastanesi   (Turkey)

^b Ko uyolu Kartal Heart Education and Research Hospital   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Autonomic nervous system; Handgrip exercise; Heart rate variability; Ipratropium; Salbutamol

Indexed keywords

IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC STIMULATION; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; FORCED EXPIRATORY VOLUME; HAND GRIP; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; LUNG FUNCTION TEST; MALE; MUSCLE EXERCISE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUPINE POSITION; COMPARATIVE STUDY; DRUG EFFECT; EXERCISE; HEART RATE; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; CHOLINERGIC ANTAGONISTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE; HEART RATE; HUMANS; IPRATROPIUM; MALE;

EID: 13844288476     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eupc.2004.07.010     Document Type: Article

References (21)

1. S. Suissa L. Blais P. Ernst Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma Eur Respir J 7 1994 1602-1609
2. W.O. Spitzer S. Suissa P. Ernst R.I. Horwitz B. Habbick D. Cockcroft et al. The use of beta-agonists and the risk of death and near-death from asthma N Engl J Med 326 1992 501-506
3. G.E. Pakes R.N. Brogden R.C. Heel T.M. Speight G.S. Avery Ipratropium bromide: A review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis Drugs 20 1980 237-266
4. W.M. Anderson Hemodynamic and non-bronchial effects of ipratropium bromide Am J Med 81 1986 45-53
5. P.M. Lehrer S.M. Hochron L. Rausch R. Carr Effects of aerosol ipratropium bromide on cardiac vagal tone Chest 105 1994 1701-1704
6. T. Jartti T. Kaila K. Tahvanainen T. Kuusela T. Vanto I. Valimaki The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis Br J Clin Pharmacol 43 1997 421-428
7. B. Eryonucu K. Uzun N. Guler M. Bilge Comparison of the acute effects of salbutamol and terbutalin on heart rate variability in adult asthmatic patients Eur Respir J 17 2001 863-867
8. J. Rossinen J. Partanen B. Stenius-Aarniala M.S. Nieminen Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease J Intern Med 243 1998 361-366
9. A.J. Dagnone J.L. Parlow Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system Chest 111 1997 1514-1518
10. R.E. Ruffin J.D. Fitzgerald A.S. Rebuck A comparison of the bronchodilator activity of Sch 1000 and salbutamol J Allergy Clin Immunol 59 1977 136-141
11. K. Gumbhir-Shah D.J. Kellerman S. DeGraw P. Koch W.J. Jusko Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects Pulm Pharmacol Ther 12 1999 353-362
12. M. Malik Heart rate variability In: D.P. Zipes J. Jalife editors. Cardiac electrophysiology: From cell to bedside 2000 W.B. Saunders Philadelphia/London/Toronto/Montreal/Sydney/Tokyo 753-762
13. B.A. Kingwell J.M. Thompson D.M. Kaye G.A. McPherson G.L. Jennings M.D. Esler Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure Circulation 90 1994 234-240
14. J. Parlow J.P. Viale G. Annat R. Hughson L. Quintin Spontaneous cardiac baroreflex activity in humans: Comparison with pharmacological responses Hypertension 25 1995 1058-1068
15. H. Hosomi M. Kawada H. Yoshida H. Motochigawa N. Uemura Y. Nishida et al. Alpha-agonist modifies baroreflex vasoconstriction by a postjunctional mechanism in dogs Clin Exp Pharmacol Physiol 15 1989 71-79
16. C.S. Garrard A. Seidler A. McKibben L.E. McAlpine D. Gordon Spectral analysis of heart rate variability in bronchial asthma Clin Auton Res 2 1992 105-111
17. J. Penttila A. Helminen T. Jartti T. Kuusea H.V. Huikuri M.P. Tulppo et al. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: Effects of various respiratory patterns Clin Physiol 21 2001 365-376
18. J.T. Bigger M.T. La Rovere R.C. Steinman J.L. Fleiss J.N. Rottman L.M. et al. Rolnitzky Comparison of baroreflex sensitivity and heart period variability after myocardial infarction J Am Coll Cardiol 14 1989 1511-1518
19. M.T. La Rovere G. Specchia A. Mortara P.J. Schwartz Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with first myocardial infarction Circulation 78 1988 816-824
20. K.E. Airaksinen M.J. Ikaheimo M.K. Linnaluoto M. Niemala J.T. Takkunen Impaired vagal heart rate control in coronary artery disease Br Heart J 58 1987 592-597
21. M. Cazzola S. Centanni C.F. Donner Anticholinergic drugs Pulm Pharmacol Ther 11 1998 381-392